Home
Company
About UsCareersWebinar
Products
ExosomesWharton’s JellyStem CellsMuse CellsComparison Chart
Providers
Med SpasSurgeonsOrthopedicsDentistryHormone Clinics
Resources
Clinical EvidenceLab InformationRevenue Calculator
Privacy PolicyTerms & Conditions

Your Patients Already Invest in Longevity. Give Them More.

Regenerative biologics complement HRT, peptide therapy, and wellness protocols, same patients, same visits, additional revenue.

Your patients are already invested. Biologics are the next step.

Hormone therapy patients are among the most engaged in any practice. They invest proactively in their health, they trust your clinical guidance, and they’re actively researching what’s available. Providers who can speak to the source of their biologics and answer documentation questions are in a stronger position than those who can’t.

α-KLOTHO, present in high concentrations in PSF-003®-derived exosomes, is the subject of published research on healthy aging and cellular protection. It is naturally present in amniotic fluid and declines significantly with age.

Wellness and longevity

How Biologics Integrate Into Your Protocols

Hormone Replacement

Applied in conjunction with HRT protocols at provider direction. Contains natural human Klotho, 300+ biologically active cytokines and growth factors, and natural human-derived hyaluronic acid.

Peptide Protocols

Layered alongside existing peptide programs at provider direction. Approximately 350 billion exosomes per cc and 300+ biologically active cytokines and growth factors from purified amniotic fluid.

Sexual Wellness

Applied in conjunction with existing sexual wellness protocols for men and women at provider direction. Contains natural human Klotho, 300+ biologically active cytokines and growth factors, and natural human-derived hyaluronic acid.

Longevity & Vitality

Applied at provider direction within longevity programs. Approximately 350 billion exosomes per cc, natural human Klotho, and 300+ biologically active cytokines and growth factors sourced from purified amniotic fluid.

Hair Restoration

Applied in conjunction with scalp protocols at provider direction. Natural collagens and growth factors from Wharton’s Jelly — components naturally present in healthy scalp tissue that decline with age.

Weight & Metabolic Wellness

Applied in conjunction with existing metabolic wellness programs at provider direction. Contains natural human-derived hyaluronic acid, chondroitin sulfate, and 300+ biologically active growth factors.

Revenue Potential

Model the financial impact of adding regenerative biologics to your hormone clinic.

$800–3K
Avg Ticket
12–30
Monthly Volume
$115K–1.1M
Annual Potential

Products for Hormone Clinics

Exosomes
  • ~350 billion exosomes per cc
  • 300+ biologically active cytokines and growth factors
  • Natural human Klotho
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
Stem Cells
  • MSC-derived, umbilical cord Wharton’s Jelly
  • 10M–150M cells per vial
  • Full donor traceability
FDA
FDA Registered
cGMP
cGMP Facility
ISO
Class 5 & 7 Cleanroom
MoCRA
MoCRA Compliant
Ethically Sourced

Ready to give your patients the next step?

Your hormone therapy patients are already investing in longevity. Regenerative biologics are the natural complement to what you already offer.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy